Curaleaf Holdings (CURLF) Capital Expenditures (2019 - 2024)

Curaleaf Holdings (CURLF) recorded quarterly Capital Expenditures of $158.0 million in Q4 2024, up 668.47% quarter-over-quarter from -$27.8 million in Q3 2024, and up 205.97% on a YoY basis from $51.6 million in Q1 2024.

Curaleaf Holdings (CURLF) Capital Expenditures (2019 - 2024) Analysis & Trends

Curaleaf Holdings' Capital Expenditures history runs 6 years deep, the most recent figure standing at $158.0 million for Q4 2024.

  • In Q4 2024, Capital Expenditures rose 205.97% year-over-year to $158.0 million; the TTM figure through Dec 2024 stood at $166.5 million (down 24.77% YoY), while the FY2025 annual figure was $2.8 million, down 97.01% from the prior year.
  • Capital Expenditures was $158.0 million for Q4 2024 at Curaleaf Holdings, up from -$27.8 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $239.6 million in Q4 2022 to a low of -$54.6 million in Q4 2021.
  • Historically, Capital Expenditures has averaged $78.3 million across 5 years, with a median of $51.6 million in 2023.
  • The sharpest annual moves came in 2021 and 2022: Capital Expenditures sank 127.79% in 2021, then surged 538.92% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $196.5 million in 2020, then slumped by 127.79% to -$54.6 million in 2021, then soared by 538.92% to $239.6 million in 2022, then slumped by 78.45% to $51.6 million in 2023, then soared by 205.97% to $158.0 million in 2024.
  • The last three Capital Expenditures figures came in at $158.0 million (Q4 2024), -$27.8 million (Q3 2024), and $51.6 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 168.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 110.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 100.80 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 9.10 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 51.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 4.09 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2.04 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 8.83 Mn
10 Curaleaf Holdings - - 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 158.00 Mn
Dec 31, 2024 158.00 Mn
Sep 30, 2024 -27.79 Mn
Sep 30, 2024 -27.79 Mn
Dec 31, 2023 51.64 Mn
Dec 31, 2023 51.64 Mn
Sep 30, 2023 -15.36 Mn
Sep 30, 2023 -15.36 Mn
Dec 31, 2022 239.63 Mn
Dec 31, 2022 239.63 Mn
Dec 31, 2021 -54.59 Mn
Dec 31, 2021 -54.59 Mn
Dec 31, 2020 196.47 Mn
Dec 31, 2020 196.47 Mn
Dec 31, 2019 148.93 Mn
Dec 31, 2019 148.93 Mn